# A Study of Remimazolam Tosilate for Sedation in the ICU

> **NCT06222294** · PHASE3 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 214 (actual)

## Conditions studied

- Sedation in the ICU

## Interventions

- **DRUG:** Remimazolam Tosilate
- **DRUG:** Propofol Medium and Long Chain Fat Emulsion Injection

## Key facts

- **NCT ID:** NCT06222294
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-12
- **Primary completion:** 2024-08-13
- **Final completion:** 2024-09-24
- **Target enrollment:** 214 (ACTUAL)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06222294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06222294, "A Study of Remimazolam Tosilate for Sedation in the ICU". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06222294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*